Are reasonable restraints on drug price increases doomed by pharma lobbying?
ADOBE
Drug price increases have been on a runaway upward trend. A bill to cap prices based on inflation could stop that, but likely won't survive pharma lobbying.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario